Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument. - Wikidata - awgldk - TriplyDB

Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument.

Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument.

http://www.wikidata.org/entity/Q37703568

about

Comparison of BD phoenix to vitek 2, microscan MICroSTREP, and Etest for antimicrobial susceptibility testing of Streptococcus pneumoniae.Multicenter evaluation of the BD Phoenix Automated Microbiology System for antimicrobial susceptibility testing of Streptococcus species.

P2860

Q37410460-F942B2BE-0F56-4075-8D49-F485EF33D275 Q42637672-72F3B0B5-8868-4DCE-9785-009488019D4D

P2860

Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument.

http://www.wikidata.org/entity/Q37703568

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Detection of resistance to gat ...... e with the VITEK 2 instrument.

@en

Detection of resistance to gat ...... e with the VITEK 2 instrument.

@nl

type

label

Detection of resistance to gat ...... e with the VITEK 2 instrument.

@en

Detection of resistance to gat ...... e with the VITEK 2 instrument.

@nl

prefLabel

Detection of resistance to gat ...... e with the VITEK 2 instrument.

@en

Detection of resistance to gat ...... e with the VITEK 2 instrument.

@nl

P1433

Q37703568-8873E8D8-B467-418E-B757-2181AB5CC6DC

P1476

Q37703568-6DA15C2C-D89D-4267-B60E-FB2297804456

P2093

Q37703568-05DE1D5C-577F-4173-A72C-16241466F4A6

Q37703568-3F3510A3-FCEF-4E41-843D-5E7C896C8CDF

Q37703568-C3FDB065-F853-4B83-8A1F-E5D615B8A753

Q37703568-EB4BB59C-52D6-4E5A-BDCA-28C8F33E1FAA

P2860

Q37703568-2BB11C92-BF33-40F4-B90F-4889B540D6B3

Q37703568-37AC4D26-85E6-4503-9E1D-57A0B96296F5

Q37703568-449EF64E-335C-46EF-8D84-A0D21D0FFD8F

Q37703568-5EC65A69-4810-400D-86BB-C838B8E0C3CB

Q37703568-65459CBA-69EB-4FF6-AB38-2CC6845E082C

Q37703568-92A7CEEE-60A9-4943-8191-2EDE9BBF717F

Q37703568-964CAF35-EE00-4D5A-8DA3-5B8B036B6472

Q37703568-BA7A2B4F-70A2-4199-9E7B-821AE0BE9F31

Q37703568-C0C8DB21-B701-46C5-85F3-E548E8EBA833

Q37703568-C92FC4EC-F9E8-4015-BBCC-F7C41728277C

P304

Q37703568-2BEBA494-99DD-47CD-B747-B682E2C53959

P31

Q37703568-D7407394-0AFA-4A0C-80D0-4C81E9D4FDFC

P356

Q37703568-8A7EB66F-0CB9-47DE-9EA5-B7E5D33F1BCE

P407

Q37703568-6C3DE8A9-F29B-4D10-8272-1F317004C7B4

P433

Q37703568-9496AB3E-1A4F-4D7E-BD74-AAA79F1894AD

P478

Q37703568-C80124AE-8C8A-4D54-847D-D8707025A3C1

P577

Q37703568-0C93DA0E-F441-4D02-B3F2-B0005E216C97

P698

Q37703568-0EC12F73-97F5-4575-8A13-7C4C92B53A10

P932

Q37703568-E5E12061-7B22-4228-B555-00CE42604B3B

P356

JCM.42.12.5928-5930.2004

P1433

Journal of Clinical Microbiology

P1476

Detection of resistance to gat ...... e with the VITEK 2 instrument.

@en

P2093

C G Whitney

http://www.w3.org/2001/XMLSchema#string

J H Jorgensen

http://www.w3.org/2001/XMLSchema#string

L M McElmeel

http://www.w3.org/2001/XMLSchema#string

S A Crawford

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study.

Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.

Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2.

Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci

Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.

Levofloxacin failure in a patient with pneumococcal pneumonia.

Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).

P304

5928-5930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.42.12.5928-5930.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15583344

http://www.w3.org/2001/XMLSchema#string

P932

535296

http://www.w3.org/2001/XMLSchema#string